Your browser is no longer supported. Please, upgrade your browser.
Settings
TECH Bio-Techne Corporation daily Stock Chart
TECH [NASD]
Bio-Techne Corporation
Index- P/E81.11 EPS (ttm)2.47 Insider Own0.40% Shs Outstand37.89M Perf Week-0.26%
Market Cap7.59B Forward P/E34.56 EPS next Y5.80 Insider Trans-39.23% Shs Float37.71M Perf Month3.74%
Income96.10M PEG7.37 EPS next Q1.05 Inst Own96.10% Short Float2.22% Perf Quarter-4.70%
Sales714.00M P/S10.64 EPS this Y1.10% Inst Trans0.72% Short Ratio5.03 Perf Half Y4.21%
Book/sh30.76 P/B6.52 EPS next Y16.42% ROA5.10% Target Price228.75 Perf Year0.92%
Cash/sh4.38 P/C45.75 EPS next 5Y11.00% ROE8.50% 52W Range132.75 - 217.15 Perf YTD38.50%
Dividend1.28 P/FCF70.45 EPS past 5Y-3.80% ROI6.90% 52W High-7.70% Beta1.20
Dividend %0.64% Quick Ratio3.20 Sales past 5Y14.80% Gross Margin66.30% 52W Low50.98% ATR5.17
Employees2250 Current Ratio4.00 Sales Q/Q6.30% Oper. Margin20.60% RSI (14)56.02 Volatility2.02% 2.54%
OptionableYes Debt/Eq0.43 EPS Q/Q-59.80% Profit Margin13.50% Rel Volume1.86 Prev Close197.50
ShortableYes LT Debt/Eq0.42 EarningsAug 06 BMO Payout50.30% Avg Volume166.20K Price200.43
Recom1.40 SMA204.24% SMA500.79% SMA2005.62% Volume309,362 Change1.48%
Jul-02-19Upgrade Janney Neutral → Buy $200 → $270
Jan-14-19Upgrade Stephens Equal-Weight → Overweight
Oct-31-18Downgrade Craig Hallum Buy → Hold
Oct-17-18Initiated Goldman Neutral $190
Jun-15-18Initiated Argus Buy $185
Jul-13-17Initiated Wells Fargo Market Perform
Feb-09-17Initiated Citigroup Buy $115
Jan-18-17Initiated Deutsche Bank Buy $115
Nov-10-16Resumed Leerink Partners Outperform $122
Jan-21-15Reiterated Robert W. Baird Outperform $102 → $104
Sep-20-13Upgrade Robert W. Baird Neutral → Outperform $76 → $90
Jun-08-12Initiated William Blair Mkt Perform
Feb-01-12Downgrade Robert W. Baird Outperform → Neutral $81 → $71
Feb-04-09Upgrade Robert W. Baird Neutral → Outperform $76 → $69
Feb-04-09Reiterated Leerink Swann Outperform $73.50 → $59.50
Oct-13-08Upgrade Leerink Swann Mkt Perform → Outperform
Apr-18-08Downgrade Robert W. Baird Outperform → Neutral $71
Sep-07-07Downgrade Leerink Swann Outperform → Mkt Perform
Jan-31-07Downgrade First Analysis Sec Overweight → Equal-Weight
Sep-16-19 09:15AM  Bio-Techne Attains ISO 9001:2015 Certification for Fetal Bovine Serum Manufacturing Facility PR Newswire
Aug-28-19 05:48PM  Bio-Techne Corp (TECH) Files 10-K for the Fiscal Year Ended on June 30, 2019 GuruFocus.com
Aug-27-19 06:07AM  Bio-Techne (NASDAQ:TECH) Shareholders Booked A 99% Gain In The Last Five Years Simply Wall St.
Aug-23-19 07:16AM  5 Tips for Making Money in Penny Stocks InvestorPlace
Aug-20-19 09:15AM  Bio-Techne Introduces Maurice Empower® Control Kit For The Maurice System PR Newswire
Aug-15-19 09:15AM  Bio-Techne To Present At The Baird 2019 Global Healthcare Conference PR Newswire
08:22AM  New Strong Sell Stocks for August 15th Zacks
Aug-13-19 09:15AM  Bio-Techne And Cygnus Technologies Announce Partnership For 3G CHO-HCP Assay PR Newswire
Aug-10-19 02:50PM  Edited Transcript of TECH earnings conference call or presentation 6-Aug-19 1:00pm GMT Thomson Reuters StreetEvents
Aug-07-19 06:45AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Aug-06-19 06:23PM  Bio-Techne Corp (TECH) Q4 2019 Earnings Call Transcript Motley Fool
08:55AM  Techne (TECH) Q4 Earnings and Revenues Lag Estimates Zacks
06:30AM  Bio-Techne Releases Fourth Quarter Fiscal 2019 Results PR Newswire
06:30AM  Bio-Techne Declares Dividend PR Newswire
Aug-05-19 01:36PM  Bio-Techne Corporation (NASDAQ:TECH): Earnings To Drop Next Year Simply Wall St.
Aug-02-19 11:46AM  Can All-Line Growth Aid CVS Health's (CVS) Earnings in Q2? Zacks
09:26AM  What's in Store for Cardinal Health (CAH) in Q4 Earnings? Zacks
Aug-01-19 11:55AM  Henry Schein (HSIC) to Post Q2 Earnings: A Beat in Store? Zacks
Jul-31-19 11:14AM  Can Patient Wins Aid GW Pharmaceuticals (GWPH) Q2 Earnings? Zacks
Jul-29-19 11:38AM  Can Bruker (BRKR) Q2 Earnings See BioSpin's Growth Revival? Zacks
Jul-25-19 07:33AM  Why Bio-Techne Corporation's (NASDAQ:TECH) High P/E Ratio Isn't Necessarily A Bad Thing Simply Wall St.
Jul-23-19 09:15AM  Uman Diagnostics And Bio-Techne Announce License And Supply Agreement For Neurofilament Light Assay PR Newswire
Jul-22-19 09:30AM  CBM or TECH: Which Is the Better Value Stock Right Now? Zacks
Jul-18-19 09:15AM  Bio-Techne To Host Conference Call On August 6, 2019, To Announce Fourth Quarter 2019 Financial Results PR Newswire
Jul-17-19 09:15AM  Bio-Techne Releases 32x8 Cartridge For The Ella Platform PR Newswire
Jul-16-19 07:01AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Jul-11-19 09:15AM  Bio-Techne Announces Commercial Release Of RNAscope® HiPlex Assay: A Multiplex In Situ Hybridization Assay For Tissues PR Newswire
Jul-09-19 10:10AM  Why the Earnings Surprise Streak Could Continue for Techne (TECH) Zacks
09:15AM  Bio-Techne CEO Chuck Kummeth Wins Entrepreneur Of The Year® 2019 Award In The Heartland PR Newswire
Jul-02-19 03:40PM  Baron Capital Commentary: Early Detection for the Win GuruFocus.com
01:53PM  At US$209, Is Bio-Techne Corporation (NASDAQ:TECH) Worth Looking At Closely? Simply Wall St.
Jun-26-19 09:07AM  Bio-Techne China Recognized With "Decade of Contribution Award" PR Newswire
Jun-25-19 04:05PM  Bio-Techne Appoints Rupert Vessey to Board of Directors PR Newswire
Jun-21-19 09:15AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Jun-18-19 10:19PM  Heres What Hedge Funds Think About Bio-Techne Corporation (TECH) Insider Monkey
04:15PM  Royce Funds Commentary: Lauren Romeo on 4 Quality Cyclicals GuruFocus.com
Jun-17-19 09:15AM  FDA Grants Breakthrough Device Designation To Bio-Techne's ExoDx Prostate IntelliScore (EPI) Test PR Newswire
Jun-13-19 04:35PM  Bio-Techne Receives Approval To Offer The ExoDx Prostate Intelliscore (EPI) Test In New York State PR Newswire
Jun-06-19 08:48AM  If You Like EPS Growth Then Check Out Bio-Techne (NASDAQ:TECH) Before It's Too Late Simply Wall St.
Jun-05-19 09:44AM  The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Gilead Sciences, Repligen, Illumina and Bio-Techne Zacks
09:02AM  Myriad Genetics Announces Study Results Of myRisk Cancer Test Zacks
Jun-04-19 05:30PM  Bio-Techne To Acquire B-MoGen Biotechnologies Inc. PR Newswire
02:12PM  5 Biotech Stocks to Buy Right Now Zacks
Jun-03-19 09:08AM  Bio-Techne To Present At The Goldman Sachs 40th Annual Global Healthcare Conference PR Newswire
May-28-19 09:15AM  Bio-Techne's New Exosome-Based Liquid Biopsies Helping To Advance Personalized Care In Lung Cancer Diagnostics PR Newswire
May-21-19 09:30AM  CBM vs. TECH: Which Stock Is the Better Value Option? Zacks
09:08AM  Bio-Techne To Present At The Jefferies 2019 Global Healthcare Conference PR Newswire
May-14-19 02:10PM  Does Bio-Techne Corporation's (NASDAQ:TECH) Past Performance Indicate A Stronger Future? Simply Wall St.
09:08AM  Bio-Techne To Present At The UBS Global Healthcare Conference PR Newswire
May-06-19 07:00AM  Roche expands partnership with Bio-Techne to offer drug discovery researchers new chromogenic detection options for mRNA ISH tissue analysis PR Newswire
May-02-19 11:46AM  Edited Transcript of TECH earnings conference call or presentation 30-Apr-19 1:00pm GMT Thomson Reuters StreetEvents
09:08AM  Bio-Techne To Present At The Bank Of America Merrill Lynch 2019 Health Care Conference PR Newswire
Apr-30-19 02:55PM  Bio-Techne Corp (TECH) Q3 2019 Earnings Call Transcript Motley Fool
06:30AM  Bio-Techne Releases Third Quarter Fiscal 2019 Results PR Newswire
06:30AM  Bio-Techne Declares Dividend PR Newswire
Apr-25-19 07:12AM  14 acquisitions later, Bio-Techne puts the checkbook away as growth unfolds American City Business Journals
Apr-23-19 10:32AM  Earnings Preview: Techne (TECH) Q3 Earnings Expected to Decline Zacks
Apr-22-19 01:07PM  Hedge Funds Dropped The Ball On Bio-Techne Corporation (TECH) Insider Monkey
09:15AM  Elpiscience and Bio-Techne Announce Strategic Collaboration PR Newswire
Apr-09-19 12:51PM  Are Bio-Techne Corporation's (NASDAQ:TECH) Interest Costs Too High? Simply Wall St.
09:07AM  Bio-Techne To Host Conference Call On April 30, 2019 To Announce Third Quarter 2019 Financial Results PR Newswire
Mar-28-19 09:09AM  Bio-Techne and NanoString Partner to Co-Develop Integrated Workflow for RNA Spatial Profiling PR Newswire
06:00AM  Bio-Techne and NanoString Partner to Co-Develop Integrated Workflow for RNA Spatial Profiling GlobeNewswire
Mar-05-19 09:08AM  Bio-Techne Scores A Trio Of CiteAb 2019 Awards PR Newswire
08:08AM  Bio-Techne To Present At The Barclays Global Healthcare Conference PR Newswire
Mar-04-19 07:15AM  Report: Exploring Fundamental Drivers Behind Stericycle, B&G Foods, QTS Realty Trust, Trimble, Electronics for Imaging, and Bio-Techne New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Feb-26-19 01:18PM  Bio-Techne Signs Strategic Cooperation Agreement with Lisen Imprinting Diagnostics PR Newswire
Feb-20-19 09:15AM  Bio-Techne To Present At The 8th Annual SVB Leerink Global Healthcare Conference PR Newswire
Feb-14-19 08:48AM  Bio-Techne (TECH) Q2 Earnings Beat, Gross Margin Declines Zacks
Feb-07-19 10:54PM  Edited Transcript of TECH earnings conference call or presentation 5-Feb-19 2:00pm GMT Thomson Reuters StreetEvents
Feb-05-19 07:29PM  Bio-Techne Corp (TECH) Q2 2019 Earnings Conference Call Transcript Motley Fool +6.07%
07:45AM  Techne (TECH) Q2 Earnings and Revenues Surpass Estimates Zacks
06:30AM  Bio-Techne Releases Second Quarter Fiscal 2019 Results PR Newswire
06:30AM  Bio-Techne Declares Dividend PR Newswire
Feb-01-19 10:30AM  What Bio-Techne Corporations (NASDAQ:TECH) ROE Can Tell Us Simply Wall St.
Jan-31-19 02:26PM  ExoDx® Prostate(IntelliScore) (EPI) Recommended in National Comprehensive Cancer Network Guidelines for Prostate Cancer Early Detection PR Newswire
Jan-29-19 10:31AM  Analysts Estimate Techne (TECH) to Report a Decline in Earnings: What to Look Out for Zacks
10:29AM  Avalon GloboCare Stock Is an Expensive Mystery InvestorPlace
09:00AM  Bio-Techne Introduces 48-Digoxigenin Cartridge for the Ella Platform PR Newswire
Jan-28-19 09:15AM  Bio-Techne Introduces CE-SDS PLUS for Maurice System PR Newswire
Jan-25-19 02:41PM  5 Innovation-Led Stocks For The Health Care Boom Investopedia
Jan-24-19 09:00AM  Bio-Techne Launches Cell and Gene Therapy Portfolio PR Newswire
Jan-18-19 08:00PM  Five Ways to Profit from the Boom in Life Science Barrons.com
Jan-16-19 09:00AM  Bio-Techne To Host Conference Call On February 5, 2019, To Announce Second Quarter 2019 Financial Results PR Newswire
Jan-14-19 09:30AM  ANIK or TECH: Which Is the Better Value Stock Right Now? Zacks
Jan-02-19 08:19AM  Does Bio-Techne Corporation (NASDAQ:TECH) Have A Good P/E Ratio? Simply Wall St.
Dec-20-18 09:15AM  Bio-Techne To Present At The 37th Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-18-18 03:04AM  Hedge Funds Are Crazy About Bio-Techne Corporation (TECH) Insider Monkey
Dec-06-18 12:14PM  Should You Think About Buying Bio-Techne Corporation (NASDAQ:TECH) Now? Simply Wall St.
Dec-04-18 09:15AM  Bio-Techne Releases GMP ROCK Inhibitor and CHIR 99021 for Stem Cell Therapy PR Newswire
Nov-20-18 09:15AM  Bio-Techne To Present At The Citi 2018 Global Healthcare Conference PR Newswire
06:31AM  New Strong Sell Stocks for November 20th Zacks
Nov-08-18 05:05PM  The List: Corporate board pay climbing? Not in Minnesota at least not this year American City Business Journals
Nov-03-18 06:16PM  Edited Transcript of TECH earnings conference call or presentation 30-Oct-18 1:00pm GMT Thomson Reuters StreetEvents
Nov-02-18 07:30AM  Report: Exploring Fundamental Drivers Behind Equity Lifestyle Properties, AvalonBay Communities, Kadant, Mastercard, Bio-Techne, and Erie Indemnity New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-31-18 12:42PM  What Did Bio-Techne Corporations (NASDAQ:TECH) CEO Take Home Last Year? Simply Wall St.
Oct-30-18 02:54PM  Bio-Techne Corp (TECH) Q1 2019 Earnings Conference Call Transcript Motley Fool -6.26%
07:00AM  Bio-Techne Releases First Quarter Fiscal 2019 Results PR Newswire
07:00AM  Bio-Techne Declares Dividend PR Newswire
Oct-26-18 09:15AM  Bio-Techne To Present At The 2018 Stephens NY Investment Conference PR Newswire
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments and services for the research and clinical diagnostic markets worldwide The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment offers reagent solutions, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera reagents, and cell selection technologies. This segment also provides analytical solutions, including manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. In addition, it offers various products, which serves as predictive biomarkers and therapeutic targets for various human diseases and conditions, such as cancer, autoimmunity, diabetes, hypertension, obesity, inflammation, neurological disorders, and kidney failure. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including Food and Drug Administration -regulated controls, calibrators, blood gas and clinical chemistry controls, and other reagents for original equipment manufacturers and clinical customers, as well as a portfolio of clinical molecular diagnostic oncology assays, including the ExoDx Prostate test for prostate cancer diagnosis. This segment also manufactures and sells tissue-based in-situ hybridization assays for research and clinical use. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. It has strategic partnership with NanoString Technologies. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kummeth Charles R.Chief Executive OfficerSep 09Buy185.0020037,000100Sep 11 04:42 PM
Kummeth Charles R.Chief Executive OfficerAug 13Option Exercise67.467,410499,879110,877Aug 15 04:45 PM
BAUMGARTNER ROBERT VDirectorAug 07Buy191.0650095,5308,726Aug 09 04:12 PM
Kummeth Charles R.Chief Executive OfficerJul 10Option Exercise67.4616,9691,144,729109,145Jul 12 04:18 PM
Kummeth Charles R.Chief Executive OfficerJul 10Sale213.1216,9693,616,42892,176Jul 12 04:18 PM
Kummeth Charles R.Chief Executive OfficerJul 09Option Exercise67.4615,0371,014,396107,213Jul 10 04:46 PM
Kummeth Charles R.Chief Executive OfficerJul 09Sale212.4315,0373,194,34092,176Jul 10 04:46 PM
Kummeth Charles R.Chief Executive OfficerJul 08Option Exercise67.4617,9941,213,875110,170Jul 10 04:46 PM
Kummeth Charles R.Chief Executive OfficerJul 08Sale212.7517,9943,828,18492,176Jul 10 04:46 PM
Eansor Norman DavidSVP - Novus BiologicalsJun 12Sale215.003,117670,1550Jun 14 04:13 PM
HIGGINS JOHN LDirectorJun 04Option Exercise63.035,000315,1508,526Jun 06 04:30 PM
HIGGINS JOHN LDirectorJun 04Sale203.675,0001,018,3463,526Jun 06 04:30 PM
Furlow Brenda S.SVP - General CounselMay 24Option Exercise0.005,40007,589May 29 04:29 PM
Furlow Brenda S.SVP - General CounselMay 24Sale200.005,4001,080,0002,189May 29 04:29 PM
Hippel JamesChief Financial OfficerMay 01Option Exercise86.2535,0003,018,75039,382May 02 04:14 PM
Kelderman KimPresident, Diagnostics & GenomMay 01Option Exercise202.131,667336,9511,667May 02 04:18 PM
Hippel JamesChief Financial OfficerMay 01Sale203.0835,0007,107,6814,382May 02 04:14 PM